Minnesota businesses raised nearly $500 million in venture capital the first half of 2021, a sizable jump from the $350 million raised at the same time last year.
But the state's companies raised $2 billion in the second half of 2020 and it will be difficult to match that level of investment this year.
"Last year set a record for VC financings, but we're seeing some larger financings this year, too," said Jeff Hinck, managing partner of Rally Ventures of suburban Minneapolis and Silicon Valley. "While the total [Minnesota] number might not top last year, it's still likely to be a large number."
U.S. firms already have raised $150 billion through June, compared with $164 billion in all of 2020, a record year for the industry, according to PitchBook and the National Venture Capital Association (NVCA).
Health care and med-tech continue to be favorites in Minnesota.
In the second quarter, 36 early-stage medical equipment and health care companies in Minnesota raised a total of $52 million, according to Medical Alley, the Golden Valley-based association that supports the state's medical device and health care industry. Of that capital, $30 million went to medical device companies, followed by digital health at $17 million, and biotechnology and pharmaceuticals at $2.4 million.
Twenty-four of the 36 companies raised less than $1 million. Among the companies raising funds last quarter was Minneapolis-based Foxo Technologies ($10 million), whose technology develops predictive models for researchers and insurers that can be applied toward lifespan and wellness analysis. Foxo has raised a total of $40 million.
The money will be used to purchase Memorial Life Insurance Co. of America, which will be renamed Foxo Life.